- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07236450
Use of a Mobile Application for Tracking Physical Activity in the Management of Metabolic Syndrome in Primary Care (IMAFIL)
Exploring the Role of a Mobile Application for Physical Activity Tracking in the Management of Metabolic Syndrome in Primary Care
This study will explore whether integrating a mobile app to track physical activity-recommended by family doctors during routine primary care visits-can help individuals with metabolic syndrome become more active. Participants will be randomly assigned to one of two groups: the intervention group will use the mobile app combined with an activity-tracking wristband; the control group will receive usual care without digital tools.
Family doctors will introduce and support the use of the mobile app during standard consultations. The study will also assess physicians' perceptions of using digital technologies, such as mobile apps and telemedicine, to encourage physical activity.
Researchers will monitor the frequency of app use, step counts and changes in physical activity habits over time.
The primary goal is to determine whether digital health tools can be feasibly implemented in primary care to promote healthier lifestyles and improve chronic disease management in people with metabolic syndrome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study examines the impact of a mobile application for tracking physical activity (PA) on the management of metabolic syndrome in a primary care setting. It also explores family physicians' attitudes and behavioral intentions regarding the adoption of telemedicine tools for health promotion.
This is a two-arm, parallel-group, superiority randomized controlled pilot study. Adult patients diagnosed with metabolic syndrome, who own a compatible smartphone, will be recruited from primary care units. Eligible participants will be randomly assigned to one of two groups: an intervention group, receiving a mobile health application (Polis Saúde®) integrated with a wearable PA-tracking device (Fitbit Inspire 3), or to a control group receiving the usual care without digital tools. Follow-up assessments will be conducted at baseline and 6 months.
The mobile application offers personalized motivational messages, health education content, and real-time PA monitoring. Data will be collected on app usage, engagement with motivational content, step counts, and participant feedback. Clinical and anthropometric data, such as lipid profiles, fasting glucose, blood pressure, BMI, and waist circumference, will also be collected.
Primary outcomes include adherence to the intervention (app usage, engagement with motivational content), retention, step count data, and dropout rates. Secondary outcomes include assessment of physical literacy, PA habits (via IPAQ), app usage metrics (frequency, session duration, feedback responses, completion and dismissal rates, etc).
The study will further assess family physicians' attitudes and intentions toward telemedicine (using the PAIT questionnaire).
Data will be analyzed using descriptive and inferential statistics, including regression and survival models.
The study aims to assess the feasibility, adherence, and potential effectiveness of mobile health technologies for promoting PA and managing chronic conditions in primary care. It will also provide insights into the behavioral determinants of physician adoption of digital health tools. The findings will inform future large-scale trials and contribute to clinical strategies and public health policies that integrate digital health solutions into chronic disease care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Portugal
-
Coimbra, Portugal, Portugal, 3000-011
- USF Cruz de Celas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years or older;
- Diagnosed with metabolic syndrome;
Presence of at least one of the following ICPC-2 (International Classification of Primary Care - 2nd edition), used in primary health care:codes in the medical record:
- T83 (Overweight) or T82 (Obesity), with waist circumference ≥ 94 cm (men) or ≥ 80 cm (women)
- T89 (Non-insulin-dependent diabetes)
- T93 (Lipid metabolism disorder: HDL < 40 mg/dl for men, < 50 mg/dl for women; or triglycerides ≥ 150 mg/dl)
- K86 (Hypertension without complications) or K87 (Hypertension with complications);
- Access to a smartphone compatible with the mobile application;
- Does not currently use any physical activity monitoring device (e.g., pedometer, smartwatch, fitness tracker);
- Willing and able to provide informed consent.
Exclusion Criteria:
- No scheduled medical appointments in the past three years;
- Refusal to participate or withdraws consent;
- Change of primary care unit during the study period;
- Pregnant at the time of enrollment or becomes pregnant during the study;
- Diagnosed mental incapacity that prevents answering questionnaires;
- Does not own a smartphone;
- Inability to use a mobile application;
- Inability to use a physical activity tracking wristband.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care Without Digital Monitoring
Participants will receive usual primary care for the management of metabolic syndrome, without access to digital tools for physical activity monitoring.
No mobile application or wearable device will be provided.
Clinical follow-up will adhere standard practice guidelines, and no additional digital health interventions will be introduced throughout the study period.
|
|
|
Experimental: Mobile Application and Wearable Device for Physical Activity Monitoring
Participants will receive usual primary care along with access to a mobile health application (Polis Saúde®) integrated with a wearable activity-tracking device (Fitbit Inspire 3).
The application provides real-time physical activity monitoring, motivational messages, and educational content.
Participants will be instructed to use the app and wearable device regularly throughout the 6-month study period.
Engagement with the app, step count data, and interaction with motivational content will be tracked to assess adherence and behavior change.
|
This intervention consists of a mobile health application (Polis Saúde®) integrated with a wearable activity tracker (Fitbit Inspire 3) designed to support physical activity monitoring and behavior change in adults with metabolic syndrome.
The mobile application delivers personalized motivational messages and educational content twice weekly and records user engagement, including app usage and interaction with content.
The wearable device continuously tracks step count and synchronizes data with the app.
Participants are encouraged to use the app and device daily over a 6-month period.
Data on adherence, physical activity, and health metrics will be collected to evaluate the impact on lifestyle and clinical outcomes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Literacy
Time Frame: Baseline, 6 months.
|
Physical literacy will be assessed using the Perceived Physical Literacy Instrument (PPLI-PT), a validated questionnaire evaluating motivation, confidence, knowledge, and participation in physical activity (5-point Likert scale, 1=Strongly disagree to 5=Strongly agree). The questionnaire was composed by nine items distributed across three dimensions:
Scoring and Interpretation: For each dimension, add the responses to the corresponding items, divide the total by the number of items in the dimension (3) to obtain the average and record the scores for each dimension separately. Higher scores in each dimension reflect a greater perceived physical literacy in the respective specific area. |
Baseline, 6 months.
|
|
EQ5D-5L
Time Frame: Baseline, 6 months
|
An instrument to describe and value health across a wide range of disease areas. 5-level EQ-5D (EuroQol instrument with 5 dimensions and 5 levels) version with five dimensions (five levels, categorical options): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Score ranges:
|
Baseline, 6 months
|
|
Physical Activity Levels
Time Frame: Baseline, 6 months
|
Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ - Short Version, 4 topics with 2 questions each one - question 1a, question 1b, question 2a, question 2b, etc). Score based on the formula: MET-min/week = MET × minutes per day × days per week (values for minutes and days per week are answered through questions 1a, 1b, 2a, 2b, 3a, 3b, 4a, 4b) Standard MET values for each activity type:
|
Baseline, 6 months
|
|
Clinical and Metabolic Health Parameters - Total cholesterol
Time Frame: Baseline, 6 months
|
Total cholesterol (mg/dl)
|
Baseline, 6 months
|
|
Clinical and Metabolic Health Parameters - HDL cholesterol
Time Frame: Baseline, 6 months.
|
HDL cholesterol (mg/dl - milligrams per deciliter)
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - LDL cholesterol
Time Frame: Baseline, 6 months
|
HDL cholesterol (mg/dl - milligrams per deciliter) -- calculated field: LDL Cholesterol = Total Cholesterol - HDL Cholesterol - (Triglycerides / 5) |
Baseline, 6 months
|
|
Clinical and Metabolic Health Parameters - nHDL cholesterol
Time Frame: Baseline, 6 months.
|
non-HDL cholesterol (mg/dl - milligrams per deciliter) -- calculated field: nHDL = Colesterol Total - Colesterol HDL
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - Triglycerides
Time Frame: Baseline, 6 months.
|
Triglycerides (mg/dl - milligrams per deciliter)
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - Fasting Glucose
Time Frame: Baseline, 6 months.
|
Fasting Glucose (mg/dl - milligrams per deciliter)
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - Glycated Hemoglobin
Time Frame: Baseline, 6 months.
|
Glycated Hemoglobin (%)
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - Aspartate Aminotransferase
Time Frame: Baseline, 6 months.
|
Aspartate Aminotransferase (U/L - units per liter)
|
Baseline, 6 months.
|
|
Clinical and Metabolic Health Parameters - Alanine Aminotransferase
Time Frame: Baseline, 6 months.
|
Alanine Aminotransferase (U/L - units per liter)
|
Baseline, 6 months.
|
|
Anthropometric Data - Body Mass Index (BMI)
Time Frame: Baseline, 6 months.
|
BMI-Body Mass Index (kg/m² - kilograms per square meter)
|
Baseline, 6 months.
|
|
Anthropometric Data - Abdominal circumference
Time Frame: Baseline, 6 months.
|
Abdominal circumference (cm)
|
Baseline, 6 months.
|
|
Anthropometric Data - Waist-to-height ratio
Time Frame: Baseline, 6 months.
|
Waist-to-height ratio (WHtR, cm-centimeter) WHtR = Waist Circumference (cm-centimeter) ÷ Height (cm-centimeter)
|
Baseline, 6 months.
|
|
Anthropometric Data - Blood pressure
Time Frame: Baseline, 6 months.
|
Blood pressure (mm Hg-millimeters of mercury)
|
Baseline, 6 months.
|
|
Anthropometric Data - Heart rate
Time Frame: Baseline, 6 months.
|
Heart rate (beat per minute)
|
Baseline, 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
App Usage Metrics - Daily Active Users
Time Frame: 6 months.
|
Number of users engaging with the app daily (integer).
|
6 months.
|
|
App Usage Metrics - Monthly Active Users
Time Frame: 6 months.
|
Number of users engaging with the app at least once per month (integer).
|
6 months.
|
|
App Usage Metrics - Session Frequency
Time Frame: 6 months.
|
How often users open the app per day or week (number/day or /week).
|
6 months.
|
|
App Usage Metrics - Session Duration
Time Frame: 6 months.
|
Average time spent in the app per session (minutes).
|
6 months.
|
|
Push Notification Engagement - Open Rate (%)
Time Frame: 6 months.
|
Percentage of push notifications opened.
|
6 months.
|
|
Push Notification Engagement - Dismissal Rate (%)
Time Frame: 6 months.
|
Percentage of notifications ignored or dismissed.
|
6 months.
|
|
Wearable activity tracker - measure 1
Time Frame: 6 months
|
Data from the wearable activity tracker (e.g., step count and app usage patterns) - DESCREVER EXATAMENTE QUAIS SÃO AS MEDIÇÕES ANALISADAS
|
6 months
|
|
Motivational Content Interaction - Message Open Rate (%)
Time Frame: 6 months.
|
Percentage of users who open motivational messages.
|
6 months.
|
|
Motivational Content Interaction - Completion Rate (%)
Time Frame: 6 months
|
Percentage of users who fully read the messages.
|
6 months
|
|
Motivational Content Interaction - Feedback Responses
Time Frame: 6 months
|
Number of "thumbs up" or "thumbs down" clicks on messages, reflecting their perceived usefulness
|
6 months
|
|
Physical Activity Metrics - Step Count Increase (%)
Time Frame: 6 months.
|
Change in the average daily step count over time.
|
6 months.
|
|
Retention Rate by Users (%)
Time Frame: 6 months.
|
Percentage of users returning to the app after 1 week, 1 month, etc.
|
6 months.
|
|
Streak Tracking
Time Frame: 6 months
|
Number of consecutive days comprising interaction with the app.
|
6 months
|
|
Dropout rate (%)
Time Frame: 6 months
|
Participants will be classified as dropouts if they have not used the mobile application and wearable device for a continuous period of 60 days.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andreia Filipa Lobo, Master, Unidade Local de Saude de Coimbra
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Metabolic Diseases
- Glucose Metabolism Disorders
- Insulin Resistance
- Hyperinsulinism
- Behavior
- Nutritional and Metabolic Diseases
- Treatment Adherence and Compliance
- Patient Acceptance of Health Care
- Metabolic Syndrome
- Motor Activity
- Health Behavior
- Patient Participation
- Equipment and Supplies
- Electrical Equipment and Supplies
- Wearable Electronic Devices
Other Study ID Numbers
- EECC-2024_4-220 e 335/25 CE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome (MetS)
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
Recep Tayyip Erdogan University Training and Research...Not yet recruitingPeriodontitis | Metabolic Syndrome (MetS)Turkey (Türkiye)
-
Far Eastern Memorial HospitalCompleted
-
King Saud UniversityCompletedPsychiatric Disorders | Energy Metabolism | Mediterranean Diet | Inflammatory Cytokines | Metabolic Syndrome (MetS) | Lipid ProfilesSaudi Arabia
-
National Cattlemen's Beef Association, a contractor...Nutrasource Pharmaceutical and Nutraceutical Services, Inc.RecruitingInflammation | Pre-Diabetes | Metabolic Syndrome (MetS)Canada
-
Ricardo MoraUniversity of Castilla-La ManchaRecruitingExercise | Hyperlactatemia | Lipolysis | Metabolic Syndrome (MetS)Spain
-
Recep Tayyip Erdogan University Training and Research...Not yet recruitingPeriodontitis | Diet, Food and Nutrition | Metabolic Syndrome (MetS)Turkey (Türkiye)
Clinical Trials on Mobile Application and Wearable Device for Physical Activity Monitoring
-
A Thousand Colibris, S.LHospital del Mar Research Institute (IMIM); Hospital Universitari Vall d'Hebron... and other collaboratorsRecruitingPostpartum Depression | Pregnancy Related | Mental Health Issue | Postpartum Anxiety | Well-Being, PsychologicalSpain
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Germany, Netherlands, Belgium
-
Region VästerbottenUmeå UniversityNot yet recruitingPhysical Activity
-
University of California, San DiegoCarol Vassiliadis FamilyCompletedObesity | Health BehaviorUnited States
-
King Khalid UniversityCompletedPhysical ActivitySaudi Arabia
-
Icahn School of Medicine at Mount SinaiAmerican Heart AssociationRecruitingCardiovascular Diseases | Atrial Fibrillation | Arrhythmias, CardiacUnited States
-
Zoll Medical CorporationNot yet recruitingHeart FailureNetherlands, Sweden, Spain, Italy, France, United Kingdom, Switzerland, Germany, Poland
-
Hanyang UniversityNational Institute of Health, KoreaCompletedTime Restricted Feeding | Non-Alcoholic Fatty Liver Disease | Mobile TechnologyKorea, Republic of
-
Yonsei UniversityCompleted